Endothelial cell dysfunction in type I and II diabetes: The cellular basis for dysfunction

Drug Development Research

Volumn 58, Issue 1, 2003, Pages 28-41

  Pannirselvam, Malarvannan ^a   Anderson, Todd J ^a   Triggle, Chris R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Smooth Muscle Research Group   (Canada)

Author keywords

"uncoupled" NOS; Endothelial dysfunction; Oxidative stress; Tetrahydrobiopterin; Type I diabetes; Type II diabetes

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ACARBOSE; ACETYLCHOLINE; ADENOVIRUS VECTOR; ADVANCED GLYCATION END PRODUCT; ALLOPURINOL; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; BRADYKININ; COPPER ZINC SUPEROXIDE DISMUTASE; GLICLAZIDE; LOSARTAN; MANGANESE SUPEROXIDE DISMUTASE; METFORMIN; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PRAVASTATIN; PROBUCOL; PROTEIN KINASE C; RAXOFELAST; SEROTONIN; SIMVASTATIN; SORBITOL; SUPEROXIDE; TETRAHYDROBIOPTERIN; TROGLITAZONE; UNINDEXED DRUG; ZOPOLRESTAT;

BIOAVAILABILITY; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DISEASE COURSE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSFER; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VITAMIN SUPPLEMENTATION;

EID: 0037287918     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10127     Document Type: Conference Paper

References (170)

1. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H, Ishibashi S, Yazaki Y, Makuuchi M. 1998. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784-1788.
2. Ammar RF Jr, Gutterman DD, Brooks LA, Dellsperger KC. 2000. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc Res 47:595-601.
3. Andrew PJ, Mayer B. 1999. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43:521-531.
4. Avogaro A, Piarulli F, Valerio A, Miola M, Calveri M, Pavan P, Vicini P, Cobelli C, Tiengo A, Calo L, Del Prato S. 1997. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 46:1040-1046.
5. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853.
6. Bucala R, Tracey KJ, Cerami A. 1991. Advanced glycosylation products quench nitric oxide and mediate defective endotheliumdependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438.
7. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. 2000. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746-751.
8. Cai H, Harrison DG. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840-844.
9. Calles-Escandon J, Cipolla M. 2001. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52.
10. Calver A, Collier J, Vallance P. 1992. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90: 2548-2554.
11. Ceriello A, dello RP, Amstad P, Cerutti P. 1996. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 45:471-477.
12. Chang KC, Chung SY, Chong WS, Suh JS, Kim SH, Noh HK, Seong BW, Ko HJ, Chun KW. 1993. Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocintreated rats. J Pharmacol Exp Ther 266:992-1000.
13. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. 2000. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 36:1461-1466.
14. Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, Mervaala EM. 2001. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37:433-439.
15. Chowienezyk PJ, Brett SE, Gopaul NK, Meeking D, Marchetti M, Russell-Jones DL, Anggard EE, Ritter JM. 2000. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologia 43:974-977.
16. Cinar MG, Ulker S, Alper G, Evinc A. 2001. Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats. Pharmacology 62:56-64.
17. Collis J, Cheetham C, Dembo L, O'Driscoll J, Stanton K, Taylor R, Green D. 2000. Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus. Diabet Med 17:553-554.
18. Cosentino F, Katusic ZS. 1995. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91:139-144.
19. Cosentino F, Luscher TF. 1999, Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res 43:274-278.
20. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. 1997. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28.
21. Cosentino F, Patton S, d'Uscio LV, Werner ER, Werner-Felmayer G, Moreau P, Malinski T, Luscher TF. 1998. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 101:1530-1537.
22. Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, Luscher TF. 2001. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 21:496-502.
23. Curcio F, Ceriello A. 1992. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790.
24. Davies AJ, Bone AJ, Wilkin TJ, Rokos H, Cole DR. 1994. Serum biopterin - a novel marker for immune activation during prediabetes in the BB rat. Diabetologia 37:466-470.
25. De Vriese An S, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. 2000a. Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974.
26. De Vriese An S, Van de Voorde J, Blom HJ, Vanhoutte PM, Verbeke M, Lameire NH. 2000b. The impaired renal vasodilator response attributed to endothelium-derived hypelpolarizing factor in streptozotocin-induced diabetic rats is restored by 5-methyltetrahydrofolate. Diabetologia 43:1116-1125.
27. Diederich D, Skopec J, Diederich A, Dai FX. 1994. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153-H1161.
28. Ding H, Triggle CR. 2002. Relaxing blood vessels: are there novel endothelium-derived mediators to be found and can their discovery lead to the development of new therapeutic agents? Pharmaceut News 8(6):42-49.
29. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. 2001. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 37:554-560.
30. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. 2000. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106:483-491.
31. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. 1993. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Colch) 85:687-693.
32. Farkas K, Sannan B, Jermendy G, Somogyi A. 2000. Endothelial nitric oxide in diabetes mellitus: too much or not enough? Diabetes Nutr Metab 13:287-297.
33. Feletou M, Vanhoutte PM. 2000 Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacol Sin 21:1-18.
34. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
35. Furman BL, Sneddon P. 1993. Endothelium-dependent vasodilator responses of the isolated mesenteric bed are preserved in longterm streptozotocin diabetic rats. Eur J Pharmacol 232:29-34.
36. Gabbay KH. 1973. The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836.
37. Garcia SF, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C. 2001 Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7:108-113.
38. Gazis A, White DJ, Page SR, Cockcroft JR. 1999. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 16:304-311.
39. Gebremedhin D, Koltai MZ, Pogatsa G, Magyar K, Hadhazy P. 1988. Influence of experimental diabetes on the mechanical responses of canine coronary arteries: role of endothelium. Cardiovasc Res 22:537-544.
40. Giugliano D, Ceriello A, Paolisso G. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267.
41. Gopaul NK, Manraj MD, Hebe A, Lee Kwai YS, Johnston A, Carrier MJ, Anggard EE. 2001. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44:706-712.
42. Gross SS, Levi R, Madera A, Park KH, Vane J, Hattori Y. 1993. Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. Adv Exp Med Biol 338:295-300.
43. Gryglewski RJ, Pahner RM, Moncada S. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456.
44. Haffner SM, Lehto S, Ronnemaa T, Pyoralak K, Laakso M. 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234.
45. Hattori Y, Kawasaki H, Abe K, Kanno M. 1991. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094.
46. Head RJ, Longhurst PA, Panek RL, Stitzel RE. 1987. A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol 91:275-286.
47. Heitzer T, Krohn K, Albers S, Meinertz T. 2000. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 43:1435-1438.
48. Heller R, Munscher-Paulig F, Grabner R, Till U. 1999. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274:8254-8260.
49. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. 2001. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276:40-47.
50. Heygate KM, Lawrence IG, Bennett MA, Thurston H. 1995. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol 116: 3251-3259.
51. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14-E22.
52. Hiragushi K, Sugimoto H, Shikata K, Yamashita T, Miyatake N, Shikata Y, Wada J, Kumagai I, Fukushima M, Makino H. 2001. Nitric oxide system is involved in glomerular hyperfiltration [in Japanese]. Diabetes Res Clin Pract 53:149-159.
53. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242.
54. Hurshman AR, Krebs C, Edmondson DE, Huynh BH, Marletta MA. 1999. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. Biochemistry 38:15689-15696.
55. Ishii M, Shimizu S, Momose K, Yamamoto T. 1999. SIN-1-induced cytotoxicity in cultured endothelial cells involves reactive oxygen species and nitric oxide: protective effect of sepiapterin. J Cardiovasc Pharmacol 33:295-300.
56. Ishii M, Shimizu S, Nagai T, Shiota K, Kiuchi Y, Yamamoto T. 2001. Stimulation of tetrahydrobiopterin synthesis induced by insulin: possible involvement of phosphatidylinositol 3-kinase. Int J Biochem Cell Biol 33:65-73.
57. Jaimes EA, Sweeney C, Raij L. 2001. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 38:877-883.
58. Jiang J, Valen G, Tokuno S, Thoren P, Pernow J. 2000. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin. Br J Pharmacol 131:1255-1261.
59. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516.
60. Kagota S, Yamaguchi Y, Nakamura K, Kunitomo M. 2000. Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus. Gen Pharmacol 34:201-209.
61. Kamata K and Kobayashi T. 1996. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol 119:583-589.
62. Kamata K, Nakajima M, Sugiura M. 1999. Effects of superoxide dismutase on the acetylcholine-induced relaxation response in cholesterol-fed and streptozotocin-induced diabetic mice. J Smooth Muscle Res 35:33-46.
63. Kappagoda T, Jayakody L, Rajotte R, Thomson AB, Senaratne MP. 1989. Endothelium-dependent relaxation to acetylcholine in the aorta of streptozotocin induced diabetic-rat and the BB-diabetic rat. Clin Invest Med 12:187-193.
64. Karasu C, Soncul H, Altan VM. 1995. Effects of non-insulin dependent diabetes mellitus on the reactivity of human internal mammary artery and human saphenous vein. Life Sci 57:103-112.
65. Katusic ZS. 1996. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20:443-448.
66. Katusic ZS. 2001. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281:H981-H986.
67. Katusic ZS, Vanhoutte PM. 1989. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 257: H33-H37.
68. Katusic ZS, Stelter A, Milstien S. 1998. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 18:27-32.
69. Kaufman S. 1991. Some metabolic relationships between biopterin and folate: implications for the methyl trap hypothesis. Neurochem Res 16:1031-1036.
70. Kinoshita H, Katusic ZS. 1996. Exogenous tetrahydrobiopterin causes endothelium-dependent contractions in isolated canine basilar artery. Am J Physiol 271:H738-H743.
71. Kinoshita H, Milstien S, Wambi C, Katusic ZS. 1997. Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol 273:H718-H724.
72. Klatt P, Heinzel B, Mayer B, Ambach E, Werner-Felmayer G, Wachter H, Werner ER. 1992. Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor. FEBS Lett 305:160-162.
73. Klatt P, Schmidt K, Uray G, Mayer B. 1993. Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-Larginine as an intermediate. J Biol Chem 268:14781-14787.
74. Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER, Mayer B. 1994. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem 269: 13861-13866.
75. Kobayashi T, Kamata K. 1999. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br J Pharmacol 127:835-842.
76. Kobayashi T, Kamata K. 2001. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis 155:313-320.
77. Kobayashi T, Matsumoto T, Kamata K. 2000. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br J Pharmacol 131:231-238.
78. Koya D, King GL. 1998. Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866.
79. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dube GP. 2001. Influence of Type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38:578-589
80. Laight DW, Carrier MJ, Anggard EE. 2000. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457-464.
81. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. 2001. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:1282-1288.
82. Lund DD, Faraci FM, Miller FJ Jr, Heistad DD. 2000. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101:1027-1033.
83. Makimattila S, Liu ML, Vakkilainen J, Schlenzka A, Lahdenpera S, Syvanne M, Mantysaari M, Summanen P, Bergholm R, Taskinen MR, Yki-Jarvinen H. 1999. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 22:973-981.
84. Marinos RS, Zhang W, Wu G, Kelly KA, Meininger CJ. 2001. Tetrahydrobiopterin levels regulate endothelial cell proliferation. Am J Physiol Heart Circ Physiol 281:H482-H489.
85. Mather KJ, Anderson TJ, Verma S. 2001a. Insulin action in the vasculature: Physiology and Pathophysiology. J Vasc Res 38: 415-422.
86. Mather KJ, Verma S, Anderson TJ. 2001b. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37:1344-1350.
87. Mayer B, Werner ER. 1995. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunym Schmied Arch Pharmacol 351:453-463.
88. Mayer B, Klatt P, Werner ER, Schmidt K. 1995. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 270:655-659.
89. McDonald LJ, Murad F. 1995. Nitric oxide and cGMP signaling. Adv Pharmacol 34:263-275.
90. McGuire JJ, Ding H, Triggle CR. 2001. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can J Physiol Pharmacol 79:443-470.
91. McIntyre CA, Hadoke PW, Williams BC, Lindsay RM, Elliott AI, McKnight JA. 2001. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type I diabetes. Clin Sci (Colch) 100:311-318.
92. McNally PG, Watt PA, Rimmer T, Burden AC, Hearnshaw JR, Thurston H. 1994. Impaired contraction and endotheliumdependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci (Colch) 87: 31-36.
93. McNamee CJ, Kappagoda CT, Kunjara R, Russell JC. 1994. Defective endothelium-dependent relaxation in the JCR:LAcorpulent rat. Circ Res 74:1126-1132.
94. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. 1992. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776.
95. Meininger CJ, Marinos RS, Hatakeyama K, Martinez-Zaguilan R, Rojas JD, Kelly KA, Wu G. 2000. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 349:353-356.
96. Michel T, Feron O. 1997. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100:2146-2152.
97. Milstien S, Katusic Z. 1999. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263:681-684.
98. Milstien S, Kaufman S. 1975. Studies on the phenylalanine hydroxylase system in liver slices. J Biol Chem 250:4777-4781.
99. Moncada S, Vane JR. 1978. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30:293-331.
100. Nichol CA, Smith GK, Duch DS. 1985. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu Rev Biochem 54:729-764.
101. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. 1993. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025.
102. O'Brien SF, McKendlick JD, Radomski MW, Davidge ST, Russell JC. 1998. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. Can J Physiol Pharmacol 76:72-76.
103. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R. 1997. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 100:678-684.
104. O'Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, Taylor R. 1999. Improvement in endothelial function by angiotensinconverting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 33:1506-1511.
105. Otter DJ, Chess-Williams R. 1994. The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats. Br J Pharmacol 113:576-580.
106. Ozyazgan S, Unlucerci Y, Bekpinar S, Akkan AG. 2000. Impaired relaxation in aorta from streptozotocin-diabetic rats: effect of aminoguanidine (AMNG) treatment. Int J Exp Diabetes Res 1:145-153.
107. Palmer RM, Ferrige AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of eiidothelium-derived relaxing factor. Nature 327:524-526.
108. Palmer AM, Gopaul N, Dhir S, Thomas CR, Poston L, Tribe RM. 1998. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation. Diabetologia 41:157-164.
109. Pannirselvam M, Verma S, Anderson TJ. 2002. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (dbldb-1-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136:255-263.
110. Paolisso G, Tagliamonte MR, Barbieri M, Zito GA, Gambardella A, Varricchio G, Ragno E, Varricchio M. 2000. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 85:109-115.
111. Pieper GM. 1997. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 29:8-15.
112. Pieper GM. 1999. Enhanced, unaltered and impaired nitric oxidemediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42:204-213.
113. Pieper GM, Siebeneich W. 1998. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 32:101-105.
114. Piercy V, Taylor SG. 1998. A comparison of spasmogenic and relaxant responses in aortae from C57/BL/KsJ diabetic mice with those from their non-diabetic litter mates. Pharmacology 56: 267-275.
115. Pinkney JH, Downs L, Hopton M, Mackness MI, Bolton CH. 1999. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E. Diabet Med 16:993-999.
116. Poston L, Taylor PD. 1995. Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci (Colch) 88:245-255.
117. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. 1992. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267:24173-24176.
118. Prabhakar SS. 2001. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol Renal Physiol 281:F179-F188.
119. Price KD, Price CS, Reynolds RD. 2001. Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis. Atherosclerosis 158:1-12.
120. Rajagopalan S, Harrison DG. 1996. Reversing endothelial dysfunction with ACE inhibitors. A new trend. Circulation 94:240-243.
121. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Piccoli A, Valentini U, Cimino A, Girelli A, Salvetti M, De Ciuceis C, Tiberio GA, Giulini SM, Sleiman I, Monteduro C, Rosei EA. 2001. Endothelial dysfunction in small resistance arteries of patients with noninsulin-dependent diabetes mellitus. J Hypertens 19:913-919.
122. Rodriguez-Manas L, Angulo J, Peiro C, Llergo JL, Sanchez-Ferrer A, Lopez-Doriga P, Sanchez-Ferrer CF. 1998. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 123:1495-1502.
123. Rosen P, Ballhausen T, Bloch W, Addicks K. 1995. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38: 1157-1168.
124. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236-2243.
125. Rubanyi GM. 1993. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22(Suppl 4):S1-14.
126. Saenz DT, I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. 1989. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025-1030.
127. Sekiya M, Suzuki J, Watanabe K, Funada J, Otani T, Akutsu H. 2001. Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with noninsulin-dependent diabetes mellitus. Jpn Circ J 65:487-490.
128. Sellers DJ, Chess-Williams R. 2000. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats. J Auton Pharmacol 20:15-22.
129. Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, Kikkawa R. 1999. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta. Diabetes 48:2437-2445.
130. Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A. 2000. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulinresistant rats. Circ Res 87:566-573.
131. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. 1996. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem 271:23928-23937.
132. Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. 2000. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 36:94-102.
133. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T. 1993. Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42:148-153.
134. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610.
135. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T. 1997. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99: 41-46.
136. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. 1999. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84:3212-3216.
137. Taylor PD, Poston L. 1994. The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol 113:801-808.
138. Tesfamariam B, Cohen RA. 1992. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326.
139. Tesfamariam B, Brown ML, Cohen RA. 1991. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648.
140. Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA. 1993. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 21:205-211.
141. Thony B, Auerbach G, Blau N. 2000. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347:1-16.
142. Tiefenbacher CP, Chilian WM, Mitchell M, DeFily DV. 1996. Restoration of endothelium -dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation 94:1423-1429.
143. Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, Kubler W. 2000. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102:2172-2179.
144. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28.
145. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. 1997. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95:2617-2622.
146. Title LM, Cummings PM, Giddens K, Nassar BA. 2000. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 36:2185-2191.
147. Vallejo S, Angulo J, Peiro C, Cercas E, Sanchez-Ferrer A, Nevado J, Llergo JL, Rodriguez-Manas L, Sanchez-Ferrer CF. 2000a. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. J Cardiovase Pharmacol 36:255-262.
148. Vallejo S, Angulo J, Peiro C, Sanchez-Ferrer A, Cercas E, Llergo JL, Nevado J, Sanchez-Ferrer CF, Rodriguez-Manas L. 2000b. Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment. J Diabetes Complic 14: 224-233.
149. van de Ree MA, Huisman MV, de Man FH, van der Vijver JC, Meinders AE, Blauw GJ. 2001. Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res 52:299-305.
150. Vasquez-Vivar J, Whitsett J, Martasek P, Hogg N, Kalyanaraman B. 2001. Reaction of tetrahydrobiopterin with superoxide: EPRkinetic analysis and characterization of the pteridine radical. Free Radic Biol Med 31:975-985.
151. Verma S, Bhanot S, Yao L, McNeill JH. 1996. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 9:370-376.
152. Verma S, Arikawa E, Yao L, Laher I, McNeill JH. 1998. Insulininduced vasodilation is dependent on tetrahydrobiopterin synthesis. Metabolism 47:1037-1039.
153. Verma S, Lovren F, Dumont AS, Mather KJ, Maitland A, Kieser TM, Triggle CR, Anderson TJ. 2000. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg 120:668-671.
154. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. 1992. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 89:12043-12047.
155. Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagai K. 1987. Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 40:643-648.
156. Waldron GJ, Ding H, Lovren F, Kubes P, Triggle CR. 1999. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol 128:653-658.
157. Watanabe Y, Sunayama S, Shimada K, Sawano M, Hoshi S, Iwama Y, Mokuno H, Daida H, Yamaguchi H. 2000. Troglitazone improves endothelial dysfunction in patients with insulin resistance. J Atheroscler Thromb 7:159-163.
158. Wei CC, Wang ZQ, Wang Q, Meade AL, Hemann C, Hille R, Stuehr DJ. 2001. Rapid kinetic studies link tetrahydrobiopterin radical formation to heme-dioxy reduction and arginine hydroxylation in inducible nitric-oxide synthase. J Biol Chem 276:315-319.
159. Werner-Felmayer G, Werner ER, Weis G, Wachter H. 1992. Tetrahydrobiopterin biosynthesis inhibition for diminishing nitric oxide production in cytokine-mediated septic shock. J Natl Cancer Inst 84:1671-1672.
160. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. 1993. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 268:1842-1846.
161. Wever RM, van Dam T, van Rijn HJ, de Groot F, Rabelink TJ. 1997. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237:340-344.
162. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. 1999. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular eontractility. J Clin Invest 104:1223-1233.
163. Williams B, Gallacher B, Patel H, Orme C. 1997. Glucoseinduced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497-1503.
164. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. 1998. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701.
165. Winters B, Mo Z, Brooks-Asplund E, Kim S, Shoukas A, Li D, Nyhan D, Berkowitz DE. 2000. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 89:2382-2390.
166. Witteveen CF, Giovanelli J, Kaufman S. 1996. Reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase. J Biol Chem 271:4143-4147.
167. Wolff SP, Dean RT. 1987. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245:243-250.
168. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897.
169. Zanetti M, Sato J, Katusic ZS, O'Brien T. 2000. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits. Diabetologia 43:340-347.
170. Zanetti M, Sato J, Katusic ZS, O'Brien T. 2001. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol 280: H2516-H2523.